|
Index of reports
> Cases resulting in hospitalization (515)
Below is the selection of adverse event reports related to Avastin (Bevacizumab) that includes cases resulting in hospitalization.
Reports 1 - 25 of 515 Next >>
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-31
Patient: female, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Uveitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Body Temperature Increased, Post Procedural Complication, Headache, Hydrocephalus, Meningitis, Cerebrospinal Fistula, Intracranial Hypotension
Adverse event resulted in: hospitalization
Suspect drug(s):
Tarceva
Dosage: 200 mg
Indication: Glioblastoma Multiforme
Start date: 2007-04-13
Avastin
Dosage: 10 mg/kg
Indication: Glioblastoma Multiforme
Start date: 2007-04-13
Other drugs received by patient: Lexapro; Keppra; Decadron; Lipitor
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-30
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Uveitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Hepatic Failure, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 590 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Aranesp
Dosage: 200 a?g, prn
Indication: Anaemia
Oxaliplatin
Dosage: 160 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Leucovorin
Dosage: 380 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-07-20
Fluorouracil
Dosage: 760 mg, unk
Start date: 2005-08-02
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Start date: 2005-08-02
End date: 2005-08-04
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Small Intestinal Obstruction, Neoplasm Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Folinic Acid; Fluorouracil; Oxaliplatin
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Coronary Artery Thrombosis, Pulmonary Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in 68 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-26
Patient: 68 year old female
Adverse reactions / side effects: Gastric Ulcer Haemorrhage, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Taxol
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Paraplatin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Avastin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-09-14
Other drugs received by patient: Durotep; Primperan; Kenalog; Novamin; Loxonin; Selbex; Adofeed; Oxynorm; Goshajinkigan; Senna Leaf; Oxycontin; Magmitt; Noritren; Laxoberon
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Pancytopenia, Septic Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Avastin
Dosage: 275 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Folinic Acid
Indication: Drug USE FOR Unknown Indication
Start date: 2006-07-10
End date: 2006-07-10
Fluorouracil
Dosage: 4600 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Camptosar
Dosage: 300 mg, unk
Indication: Colorectal Cancer
Start date: 2006-07-10
End date: 2006-07-10
Adverse event in 79 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-25
Patient: 79 year old female, weighing 80.3 kg (176.6 pounds)
Adverse reactions / side effects: Osteonecrosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Paclitaxel; Carboplatin; Synthroid; Sinemet; Actos; Lasix; Percocet; Betoptic; Protonix; Colace; Senokot; Coumadin; Dilaudid
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United States on 2007-10-25
Patient: female
Adverse reactions / side effects: Body Temperature Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 1047 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-24
Rshapo2l-Trail
Dosage: 1400 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-24
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-25
Patient: female
Adverse reactions / side effects: Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Duroferon; Fosamax; Burinex; Vitamin B-12; Maxitrol
Adverse event in 68 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-24
Patient: 68 year old female
Adverse reactions / side effects: Pyrexia, Altered State of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Taxol
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Paraplatin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-10-10
Avastin
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2007-08-01
End date: 2007-09-14
Other drugs received by patient: Durotep; Primperan; Kenalog; Novamin; Loxonin; Selbex; Adofeed; Oxynorm; Goshajinkigan; Senna Leaf; Oxycontin; Magmitt; Noritren; Laxoberon
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-24
Patient: female
Adverse reactions / side effects: Gastrointestinal Perforation, Intestinal Ischaemia, Nausea, Diarrhoea, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Taxotere
Adverse event in 76 year old female receiving Avastin (Bevacizumab)
Reported by a pharmacist from United States on 2007-10-24
Patient: 76 year old female, weighing 60.9 kg (134.0 pounds)
Adverse reactions / side effects: Confusional State
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-03
Oxaliplatin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Aranesp
Indication: Anaemia
Avastin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Avastin
Dosage: unk
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: male, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 0.5 mg, 1/month
Indication: Macular Degeneration
Start date: 2006-07-20
Lucentis
Dosage: 500 a?g, unk
Indication: Macular Degeneration
Start date: 2006-10-19
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19
Patient: female, weighing 78.1 kg (171.8 pounds)
Adverse reactions / side effects: Fluid Overload
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 15 mg/kg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-09-19
Tarceva
Dosage: 150 mg, qd
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-09-19
End date: 2007-10-03
Other drugs received by patient: 0.9% NS
Adverse event in 53 year old male receiving Avastin (Bevacizumab)
Reported by a physician from United States on 2007-10-19
Patient: 53 year old male
Adverse reactions / side effects: Respiratory Failure
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Synthroid; Oxaliplatin; Fluorouracil; Leucovorin
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a physician from United Kingdom on 2007-10-18
Patient: female
Adverse reactions / side effects: Dysphagia, Dysphonia
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Taxol
Adverse event in 76 year old female receiving Avastin (Bevacizumab)
Reported by a pharmacist from United States on 2007-10-18
Patient: 76 year old female, weighing 61.0 kg (134.2 pounds)
Adverse reactions / side effects: Claustrophobia, Respiratory Rate Increased, Global Amnesia, Cerebrovascular Accident, Macular Degeneration, Tremor, Speech Disorder, Reversible Posterior Leukoencephalopathy Syndrome, Balance Disorder, Clumsiness, Dizziness, Memory Impairment
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Adverse event in 59 year old male receiving Avastin (Bevacizumab)
Reported by a pharmacist from United States on 2007-10-18
Patient: 59 year old male, weighing 82.0 kg (180.4 pounds)
Adverse reactions / side effects: Pancreatitis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Erbitux
Indication: Colon Cancer Metastatic
Start date: 2006-11-22
End date: 2007-05-19
Avastin
Indication: Colon Cancer Metastatic
Start date: 2006-12-20
End date: 2007-09-05
Other drugs received by patient: CPT-11; Magnesium Sulfate; Benadryl
Adverse event in 40 year old female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-18
Patient: 40 year old female
Adverse reactions / side effects: Fatigue, Anorexia, Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol
Dosage: 6th cycle was started on 28-sep-oct.
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Paraplatin
Dosage: 6th cycle was started on 28-sep-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Avastin
Dosage: 6th cycle was started on 27-sep-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: female
Adverse reactions / side effects: Confusional State, Aphasia, Dizziness, Transient Ischaemic Attack
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Eutirox
Adverse event in female receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-18
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Abdominal Abscess, Appendicectomy
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin (Bevacizumab)
Other drugs received by patient: Taxol
Adverse event in male receiving Avastin (Bevacizumab)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-17
Patient: male, weighing 79.5 kg (174.9 pounds)
Adverse reactions / side effects: Malaise, Creutzfeldt-Jakob Disease, Convulsion
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Avastin
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-22
End date: 2007-01-22
Lucentis
Dosage: unk, 1/month
Indication: Drug USE FOR Unknown Indication
Start date: 2007-01-01
End date: 2007-05-01
Other drugs received by patient: Pravastatin; Quinapril HCL; Ranitidine HCL; Caltrate + D
Page 1 Next >>
|
